Several years ago, a little-known drug named Ozempic—previously used only to treat diabetes—emerged as a promising new drug ...

If you're using GLP-1 medications like Ozempic, Wegovy, or Mounjaro, you know how important it is to prioritize protein ...

While Novo Nordisk's Ozempic is the most mainstream GLP-1 medication, Eli Lilly (NYSE: LLY) has two blockbuster weight loss ...

Oprah Winfrey recently detailed how taking weight loss drugs shifted her longtime mindset about what she described as “thin ...

In the trial, patients who received a once-weekly 20 mg injection of amycretin over 36 weeks saw an impressive 22% reduction ...

Novo Nordisk's U.S.-listed shares are surging 9% Friday morning after the Danish drugmaker reported early stage results for ...

The UWMDI is the first of its kind in the Pacific Northwest, integrating state-of-the-art research programs with superb care for patients with diabetes, obesity and their complications ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to treat ...

Research identifies key factors affecting semaglutide initiation among obese individuals without diabetes, revealing ...

A class of drugs designed to fight diabetes and weight loss can help with a host of other problems, but also carry some side effects.

A study by the Department of Veterans Affairs says that drugs like Ozempic can do plenty more than just help with weight loss ...